Rodenstock had already acquired in March of 1998 a minority stake in 2C Optics. This small US manufacturer of ophthalmic Rx lenses, which employs just over 80 persons, has developed a proprietary Automated Prescription Technology process which, according to Rodenstock, is expected to revolutionize the spectacle lens industry. Protected by ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.